Rajiv Malik is Mylan's Executive Vice President in charge of Global Technical Operations. Malik served in a similar capacity for Mylan since January 2007, when Mylan acquired a controlling stake in Matrix Laboratories Limited, one of the world's largest suppliers of active pharmaceutical ingredients. As Head of Global Technical Operations, Malik oversees Mylan's global research and development (R&D) centers, and manufacturing and distribution units. He is responsible for enhancing and rationalizing Mylan's global supply chain and expanded product pipeline, as well as leveraging Matrix's capabilities across the Company. Malik has worked for more than 24 years in the global generic pharmaceutical industry. Prior to joining Matrix in 2005, Malik was Head of Global Development and Regulatory at Sandoz. He started his R&D career at Ranbaxy Laboratories, rising to Head of Generics R&D. Malik earned his master's degree in pharmaceutical technology from Punjab University, India, and has more than 60 process patents to his credit.
